Catalog

Weight Loss & Metabolic

GLP-1 class agonists, amylin analogues and metabolic research compounds studied for appetite regulation, glucose control and fat metabolism.

5 compounds

Dual GIP/GLP-1 agonist studied for substantial appetite reduction, glucose control and weight loss.

10 mg

$249

Investigational GLP-1/GIP/glucagon triple agonist studied in obesity and metabolic disease.

10 mg

$329

Long-acting amylin analogue studied primarily for appetite suppression and weight loss.

5 mg

$279

Modified HGH fragment researched for fat breakdown without the full growth effects of HGH.

5 mg

$89

Lipotropic blend with methylcobalamin (B12) studied in the context of fat metabolism and energy substrate handling.

121 mg/mL

$89